Cost of HIV treatment (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Cost of HIV treatment" in English language version.

refsWebsite

Global rank English rank

8nih.gov

4^th place

7web.archive.org

1^st place

5who.int

195^th place

302^nd place

4doi.org

2^nd place

4worldcat.org

5^th place

3nytimes.com

7^th place

2msfaccess.org

low place

1msf.org

low place

1indiatimes.com

17^th place

15^th place

1worldbank.org

231^st place

332^nd place

1pepfar.gov

low place

1itpcmena.org

low place

1harvard.edu

18^th place

17^th place

1medicinespatentpool.org

low place

1bbc.co.uk

8^th place

10^th place

1medicineslawandpolicy.org

low place

1avert.org

low place

1cdc.gov

218^th place

212^th place

1britannica.com

40^th place

58^th place

1semanticscholar.org

11^th place

8^th place

1wto.org

3,346^th place

3,227^th place

avert.org

"HIV drug resistance". AVERT. 2017-07-19. Retrieved 2018-11-10.

bbc.co.uk

news.bbc.co.uk

"Brazil to break Aids patent". BBC News. London: BBC. 23 August 2001. Retrieved 10 March 2012.

britannica.com

"ACT UP | international organization". Encyclopedia Britannica. Retrieved 2018-11-10.

cdc.gov

"Opportunistic Infections | Living with HIV | HIV Basics | HIV/AIDS | CDC". www.cdc.gov. 2018-07-23. Retrieved 2018-11-10.

doi.org

Hoen, Ellen 't; Berger, Jonathan; Calmy, Alexandra; Moon, Suerie (2011). "Driving a decade of change: HIV/AIDS, patents and access to medicines for all". Journal of the International AIDS Society. 14 (1): 15. doi:10.1186/1758-2652-14-15. ISSN 1758-2652. PMC 3078828. PMID 21439089.
Yazdanpanah, Y. (2004-02-25). "Costs associated with combination antiretroviral therapy in HIV-infected patients". Journal of Antimicrobial Chemotherapy. 53 (4): 558–561. doi:10.1093/jac/dkh142. ISSN 1460-2091. PMID 14985277.
Solem, Caitlyn T.; Snedecor, Sonya J.; Khachatryan, Alexandra; Nedrow, Katherine; Tawadrous, Margaret; Chambers, Richard; Haider, Seema; Simpson, Kit (2014-05-27). "Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population". PLOS ONE. 9 (5): e98152. Bibcode:2014PLoSO...998152S. doi:10.1371/journal.pone.0098152. ISSN 1932-6203. PMC 4035292. PMID 24866200.
Birmingham, Karen (April 2001). "South Africa vs. big pharma". Nature Medicine. 7 (4): 390. doi:10.1038/86424. ISSN 1078-8956. PMID 11283645. S2CID 27937512.

harvard.edu

ui.adsabs.harvard.edu

Solem, Caitlyn T.; Snedecor, Sonya J.; Khachatryan, Alexandra; Nedrow, Katherine; Tawadrous, Margaret; Chambers, Richard; Haider, Seema; Simpson, Kit (2014-05-27). "Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population". PLOS ONE. 9 (5): e98152. Bibcode:2014PLoSO...998152S. doi:10.1371/journal.pone.0098152. ISSN 1932-6203. PMC 4035292. PMID 24866200.

indiatimes.com

economictimes.indiatimes.com

IANS (4 June 2019). "Two-thirds of AIDS treatment drugs supplied globally by India". The Economic Times. Archived from the original on 26 October 2019. Retrieved 24 July 2019.

itpcmena.org

"The first Middle East and North Africa Community Advisory Board (MENA-CAB) - ITPC MENA". ITPC MENA. 2014-07-10. Retrieved 2018-10-30.

medicineslawandpolicy.org

"How patents, data exclusivity and SPCs interact to extend market exclusivity of medicines: the example of Truvada | Medicines Law & Policy". medicineslawandpolicy.org. 10 July 2018. Retrieved 2018-11-16.

medicinespatentpool.org

"MPP-Home". medicinespatentpool.org. Retrieved 2018-11-10.

msf.org

"Stopping Senseless Deaths | Médecins Sans Frontières (MSF) International". Médecins Sans Frontières (MSF) International. Retrieved 2018-10-30.

msfaccess.org

"UNTANGLING THE WEB OF ANTIRETROVIRAL PRICE REDUCTIONS 17th Edition" (PDF). Médecins Sans Frontières. July 2014.
"UNTANGLING THE WEB OF ANTIRETROVIRAL PRICE REDUCTIONS 18 Edition" (PDF). Médecins Sans Frontières.

nih.gov

pubmed.ncbi.nlm.nih.gov

Hoen, Ellen 't; Berger, Jonathan; Calmy, Alexandra; Moon, Suerie (2011). "Driving a decade of change: HIV/AIDS, patents and access to medicines for all". Journal of the International AIDS Society. 14 (1): 15. doi:10.1186/1758-2652-14-15. ISSN 1758-2652. PMC 3078828. PMID 21439089.
Yazdanpanah, Y. (2004-02-25). "Costs associated with combination antiretroviral therapy in HIV-infected patients". Journal of Antimicrobial Chemotherapy. 53 (4): 558–561. doi:10.1093/jac/dkh142. ISSN 1460-2091. PMID 14985277.
Solem, Caitlyn T.; Snedecor, Sonya J.; Khachatryan, Alexandra; Nedrow, Katherine; Tawadrous, Margaret; Chambers, Richard; Haider, Seema; Simpson, Kit (2014-05-27). "Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population". PLOS ONE. 9 (5): e98152. Bibcode:2014PLoSO...998152S. doi:10.1371/journal.pone.0098152. ISSN 1932-6203. PMC 4035292. PMID 24866200.
Birmingham, Karen (April 2001). "South Africa vs. big pharma". Nature Medicine. 7 (4): 390. doi:10.1038/86424. ISSN 1078-8956. PMID 11283645. S2CID 27937512.

aidsinfo.nih.gov

"Cost Considerations and Antiretroviral Therapy Limitations to Treatment Safety and Efficacy Adult and Adolescent ARV". AIDSinfo. Archived from the original on 2019-10-31. Retrieved 2018-10-30.
"Drug Resistance Understanding HIV/AIDS". AIDSinfo. Archived from the original on 2018-11-10. Retrieved 2018-11-10.

ncbi.nlm.nih.gov

Hoen, Ellen 't; Berger, Jonathan; Calmy, Alexandra; Moon, Suerie (2011). "Driving a decade of change: HIV/AIDS, patents and access to medicines for all". Journal of the International AIDS Society. 14 (1): 15. doi:10.1186/1758-2652-14-15. ISSN 1758-2652. PMC 3078828. PMID 21439089.
Solem, Caitlyn T.; Snedecor, Sonya J.; Khachatryan, Alexandra; Nedrow, Katherine; Tawadrous, Margaret; Chambers, Richard; Haider, Seema; Simpson, Kit (2014-05-27). "Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population". PLOS ONE. 9 (5): e98152. Bibcode:2014PLoSO...998152S. doi:10.1371/journal.pone.0098152. ISSN 1932-6203. PMC 4035292. PMID 24866200.

nytimes.com

Times, Philip J. Hilts and Special To the New York (19 September 1989). "AIDS DRUG'S MAKER CUTS PRICE BY 20%". The New York Times. Retrieved 2018-11-10.
Rosenberg, Tina (28 January 2001). "Look at Brazil". The New York Times. Retrieved 2018-11-10.
McNeil, Donald G. Jr. (7 February 2001). "Indian Company Offers to Supply AIDS Drugs at Low Cost in Africa". The New York Times. Retrieved 2018-11-10.

pepfar.gov

"2014 Report on Costs of Treatment in the President's Emergency Plan for AIDS Relief (PEPFAR)" (PDF). Archived from the original (PDF) on 2017-04-27.

semanticscholar.org

api.semanticscholar.org

Birmingham, Karen (April 2001). "South Africa vs. big pharma". Nature Medicine. 7 (4): 390. doi:10.1038/86424. ISSN 1078-8956. PMID 11283645. S2CID 27937512.

web.archive.org

"Cost Considerations and Antiretroviral Therapy Limitations to Treatment Safety and Efficacy Adult and Adolescent ARV". AIDSinfo. Archived from the original on 2019-10-31. Retrieved 2018-10-30.
"Increasing access to HIV treatment in middle-income countries: Key data on prices, regulatory status, tariffs and the intellectual property situation". World Health Organization. May 2014. Archived from the original on June 18, 2014.
IANS (4 June 2019). "Two-thirds of AIDS treatment drugs supplied globally by India". The Economic Times. Archived from the original on 26 October 2019. Retrieved 24 July 2019.
"2014 Report on Costs of Treatment in the President's Emergency Plan for AIDS Relief (PEPFAR)" (PDF). Archived from the original (PDF) on 2017-04-27.
"Drug Resistance Understanding HIV/AIDS". AIDSinfo. Archived from the original on 2018-11-10. Retrieved 2018-11-10.
"HIV drug resistance report 2017". World Health Organization. Archived from the original on July 23, 2017. Retrieved 2018-11-09.
"WHO | Urgent work needed to rebuild health care systems". www.who.int. Archived from the original on August 25, 2004. Retrieved 2018-11-10.

who.int

"Increasing access to HIV treatment in middle-income countries: Key data on prices, regulatory status, tariffs and the intellectual property situation". World Health Organization. May 2014. Archived from the original on June 18, 2014.
"Updated recommendations on first-line and second-line antiretroviral regimens and post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidance". World Health Organization. Retrieved 2018-10-30.
"Second-line ART for HIV-infected patients failing first-line therapy" (PDF). World Health Organization.
"HIV drug resistance report 2017". World Health Organization. Archived from the original on July 23, 2017. Retrieved 2018-11-09.
"WHO | Urgent work needed to rebuild health care systems". www.who.int. Archived from the original on August 25, 2004. Retrieved 2018-11-10.

worldbank.org

datahelpdesk.worldbank.org

"World Bank Country and Lending Groups – World Bank Data Help Desk". datahelpdesk.worldbank.org. Retrieved 2018-11-10.

worldcat.org

search.worldcat.org

Hoen, Ellen 't; Berger, Jonathan; Calmy, Alexandra; Moon, Suerie (2011). "Driving a decade of change: HIV/AIDS, patents and access to medicines for all". Journal of the International AIDS Society. 14 (1): 15. doi:10.1186/1758-2652-14-15. ISSN 1758-2652. PMC 3078828. PMID 21439089.
Yazdanpanah, Y. (2004-02-25). "Costs associated with combination antiretroviral therapy in HIV-infected patients". Journal of Antimicrobial Chemotherapy. 53 (4): 558–561. doi:10.1093/jac/dkh142. ISSN 1460-2091. PMID 14985277.
Solem, Caitlyn T.; Snedecor, Sonya J.; Khachatryan, Alexandra; Nedrow, Katherine; Tawadrous, Margaret; Chambers, Richard; Haider, Seema; Simpson, Kit (2014-05-27). "Cost of Treatment in a US Commercially Insured, HIV-1–Infected Population". PLOS ONE. 9 (5): e98152. Bibcode:2014PLoSO...998152S. doi:10.1371/journal.pone.0098152. ISSN 1932-6203. PMC 4035292. PMID 24866200.
Birmingham, Karen (April 2001). "South Africa vs. big pharma". Nature Medicine. 7 (4): 390. doi:10.1038/86424. ISSN 1078-8956. PMID 11283645. S2CID 27937512.

wto.org

"WTO | Doha Declaration explained". www.wto.org. Retrieved 2018-11-10.